White Oil Market Analysis

White Oil Market Analysis

White oil market value from the pharmaceutical grade segment will exceed USD 750 million by 2032, as a result of the mounting drug intake and the high burden of animal diseases. As per the CDC, more than 6 in 10 known infectious diseases can be spread from animals. Since the product is widely adopted in animal vaccine manufacturing, the increasing risks of zoonotic diseases will amplify the usage of pharma-grade white mineral oil. This substance is also gaining traction in the production of other pharmaceutical products such as gelatin capsules, ointments, and laxatives, further contributing to its consumption.
 

The potential outlook for medical, personal care, and cosmetic applications providing improved longevity, purity, and consistency will boost white oil market growth. The growth is owing to exceptional skin compatibility, low irritancy, low environmental impact, and resistance to bacteria and other unwanted elements. Enhanced economic conditions coupled with rapid industrialization and urbanization in the emerging countries will support the industry growth.
 

The personal care & cosmetics application segment is set to register gains at nearly 3% through 2032. White oils are emerging as a key component in emollients and moisturizers for cosmetic and personal care applications including suntan lotions, baby oil, skin creams, and makeup removers. The incorporation of such products in consumers’ daily personal care routines will therefore fuel the requirement for cosmetic ingredients such as white oil. Likewise, the robust demand for durable, pure, and consistent products, alongside increasing consumer expenditure will further expedite the usage of white oil in personal care & cosmetics applications.
 

Asia Pacific white oil market will be valued at more than USD 1.5 billion by 2032, on account of the rising prevalence of non-communicable diseases including cancer. According to the WHO, NCDs cause an estimated 9 million deaths per year, half of which are premature, in Southeast Asia. The increasing burden of such ailments is anticipated to promote the use of ingredients such as white oils in drug manufacturing applications. Additionally, the introduction of favorable policies and initiatives to support pharma sector development will further augment white oil production in the region.